Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancer

• 1. 整合表观遗传因素的缺血性脑卒中不良结局风险预测装置 [P] . 中国专利： CN110797120A . 2020-02-14
• 2. 避免藻类中的外源核酸的表观遗传沉默 [P] . 中国专利： CN112996916A . 2021-06-18
• 3. Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancer [P] . 美国专利： US8288099B2 . 2012-10-16

  机译： 表观遗传沉默环氧合酶2影响胃癌的临床结局

• 4. Epigenetic Silencing of Cyclooxygenase-2 Affects Clinical Outcome in Gastric Cancer [P] . 美国专利： US2010304376A1 . 2010-12-02

  机译： 表观遗传沉默的环氧合酶2影响胃癌的临床结果。

• 5. EPIGENETIC SILENCING OF CYCLOOXYGENASE-2 AFFECTS CLINICAL OUTCOME IN GASTRIC CANCER [P] . 欧洲知识产权局专利： EP2173899A4 . 2010-11-03

  机译： 环氧合酶-2的表位沉默影响胃癌的临床疗效

• 1. LRP5 polymorphism-A potential predictor of the clinical outcome in advanced gastric cancer patients treated with EOF regimen [J] . Xin Liu, Ming-Zhu Huang, Zhi-Yu Chen, 中国癌症研究（英文版） . 2014,第004期
• 2. Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancer. [J] . de-Maat MF, van-de-Velde CJ, Umetani N, Journal of Clinical Oncology . 2007,第31期
• 3. Identification of Long-Range Epigenetic Silencing on Chromosome 15q25 and Its Clinical Implication in Gastric Cancer [J] . Kang Jee-Youn, Song Sang-Hyun, Yun Jiyeon, American Journal of Pathology: Official Publication of the American Association of Pathologists . 2015,第3期
• 4. Identification of Long-Range Epigenetic Silencing on Chromosome 15q25 and Its Clinical Implication in Gastric Cancer [J] . Jee-Youn Kang, Sang-Hyun Song, Jiyeon Yun, The American journal of pathology. . 2015,第3期
• 5. Carcinogen Exposure and Epigenetic Silencing in Bladder Cancer [C] . CARMEN J. MARSIT, MARGARET R. KARAGAS, ALAN SCHNED, Conference on "Framing the Future in Light of the Past: Living in a Chemical World" . 2006
• 6. Clinical and Economic Outcomes for Gastric Cancer Patients Treated with Gastrectomy at Centres with and without Cancer Surgery Designation in Ontario [D] . Jeong, Yunni . 2019
• 7. A central role for G9a and EZH2 in the epigenetic silencing of cyclooxygenase-2 in idiopathic pulmonary fibrosis [O] . William R. Coward, Carol A. Feghali-Bostwick, Gisli Jenkins, -1
• 8. Epigenetic Silencing of STAT3-Targeted miR-193a, by Constitutive Activation of JAK/STAT Signaling, Leads to Tumor Progression Through Overexpression of YWHAZ in Gastric Cancer [O] . Kuo-Liang Wei, Jian-Liang Chou, Yin-Chen Chen, 2021

• 1. Mechanism and clinical significance of cyclooxygenase-2 expression in gastric cancer [J] . Bao-CanWang ,Chang-QingGuo ,ChaoSun . 世界胃肠病学杂志：英文版 . 2005,第21期
• 2. Clinical outcomes of Clutch Cutter endoscopic submucosal dissection for older patients with early gastric cancer [J] . Yoshihiro Otsuka ,Kazuya Akahoshi ,Kayoko Yasunaga . 世界胃肠肿瘤学杂志：英文版（电子版） . 2017,第10期
• 3. Polymorphisms of ERCC1, XPD, XRCC1 and XPG Predict Clinical Outcome in Advanced Gastric Cancer Patients Receiving Oxaliplatin-Based Chemotherapy in Chinese Population [J] . Jian Jiang ,Jun Liang ,Ruyong Yao . 临床肿瘤和癌症研究 . 2009,第005期
• 4. Clinical outcomes of self-expandable metal stents in palliation of malignant anastomotic strictures caused by recurrent gastric cancer [J] . Yu Kyung Cho ,Sang Woo Kim ,Kwan Woo Nam . 世界胃肠病学杂志：英文版 . 2009,第28期
• 5. 表观遗传学调控下DACH1的表达沉默通过激活TGF-b信号通路促进胃癌的侵袭转移 [C] . 闫文姬 ,吴孔明 ,杨云生 . 第八届中国肿瘤内科大会、第三届中国肿瘤医师大会暨中国抗癌协会肿瘤临床化疗专业委员会2014年学术年会 . 2014
• 6. 术前预康复对合并代谢综合征胃癌患者腹腔镜胃癌根治术后临床结局影响的随机临床研究 [A] . 王鸿雁 . 2016